LFB Biotechnologies
🏢 View company profile →10Patents
9Active
10Granted
45Portfolio score
Filing activity: Jan 24, 2005 → Apr 10, 2012 · 8 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7931895B2 | Monoclonal antibodies with enhanced ADCC function | Chemistry; Metallurgy | 19 | Expired |
| US8535668B2 | Chimeric anti-ricin antibody | Chemistry; Metallurgy | 3 | Active |
| US8802620B2 | Demannosylated recombinant factor VIII for the treatment of patients with haemophilia A | Human Necessities | 3 | Active |
| US8153124B2 | Method for treating cancer using monoclonal antibodies | Chemistry; Metallurgy | 2 | Active |
| US8492524B2 | Method for extracting a protein from milk | Chemistry; Metallurgy | 2 | Active |
| US8124078B2 | Method for treating idiopathic thrombocytopenic purpura using monoclonal antibodies | Chemistry; Metallurgy | 0 | Active |
| US8178093B2 | Method for treating infectious disease using monoclonal antibodies | Chemistry; Metallurgy | 0 | Active |
| US8357370B2 | Anti-D monoclonal antibodies | Chemistry; Metallurgy | 0 | Active |
| US8038993B2 | Cytotoxic antibodies directed against antibodies inhibiting factor VIII | Chemistry; Metallurgy | 0 | Active |
| US8025803B2 | Use of a chromatography substrate for reducing the amount of ADAMTS13 in a solution derived from plasma | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.